Global Action To End Smoking Inc.

Global Action to End Smoking operates as a scientific grantmaker with a rigorous RFP-driven process and a formal preproposal gate — no full proposals are accepted on first submission. The organization's charitable mission is explicitly narrow: ending combustible tobacco use, the leading preventable cause of death globally, through research, cessation education, and agricultural transformation in tobacco-farming regions. Three program areas define the grant portfolio: Health and Science Research, Cessation Education, and Agricultural Transformation.

The organization strongly favors academic institutions, independent research centers, and science organizations with verifiable track records in epidemiology, behavioral health, clinical studies, product research, policy, or economics. Commercial entities may be considered, but the institutional research profile is the baseline expectation. A structural advantage attaches to applicants with a LMIC or marginalized-community nexus: the organization has made low- and middle-income countries and underserved populations a primary stated priority across its 175+ awarded grants spanning 46 countries and four continents.

Relationship progression follows three pathways. Competitive RFPs are issued periodically — the 2025 cycle ran January 30 through May 23 — and distinguish between Small Scale and Large Scale project categories within each program area. Direct solicitation occurs when program staff identify organizations as strong fits for specific priorities. Unsolicited investigator-initiated proposals are accepted when an intake window is open, though as of April 2026 neither RFPs nor unsolicited proposals are actively being received. First-time applicants should use the current period to monitor the RFP page and prepare preproposal materials so they can move quickly when the next window opens.

Two requirements are non-negotiable: Open Science compliance (data sharing and publication plans must be baked into the project design) and conflict-of-interest disclosure. Any tobacco industry affiliation — historical or current — for key personnel is disqualifying. Given the organization's own PMI-funding history (which ended September 2023), this policy is enforced with acute scrutiny. The organization holds a Candid Platinum Seal of Transparency (2024), reflecting strong governance expectations. IRS data confirms officer compensation of $1.85M in FY2023 on a $152M asset base — this is a professionally staffed scientific funder, not a community grant program, and proposals must match that standard.

Global Action to End Smoking's grantmaking has undergone a significant structural transition over five fiscal years, driven by changes in its primary revenue source. At its peak in FY2019, the organization received $80M in contributions and disbursed $69.2M in total giving, including $41M in direct grants paid. By FY2023, annual grants paid contracted to $21.7M even as total assets surged to $152.1M — reflecting a $140M contribution received that year, widely understood to be a final endowment transfer from Philip Morris International before the funding relationship ended in September 2023.

The five-year grants-paid trajectory is: $41.0M (FY2019) → $25.5M (FY2020) → $25.3M (FY2021) → $27.7M (FY2022) → $21.7M (FY2023). The FY2023 payout rate represents approximately 14% of the $152M asset base — a conservative initial deployment consistent with a newly endowed foundation establishing a sustainable long-term operating rate. With the endowment now secured and officer compensation stable at $1.8–2.1M annually across the period, annual grantmaking is expected to stabilize in the $25–40M range going forward.

IRS Form 990 data shows three major grantees (disclosed as attachments) collectively received $127.8M across five grants over the reporting period, with per-grant averages of approximately $25.6M. These reflect institutional or center-level multi-year commitments, not typical project grants. The active RFP structure, however, introduces a distinct Small Scale versus Large Scale tier system, strongly implying the organization also deploys project-level grants at lower amounts — though RFP documentation does not publicly specify funding caps.

By program area, recent grantee data from the website confirms Health and Science Research and Cessation Education as the two dominant funded tracks. Grantees include Cornell University, San Diego State University Research Foundation, Northwell Health, and Urban Institute in the U.S., alongside international organizations in Ukraine, Pakistan, and the UK. Agricultural Transformation, the third program area, appears to receive substantially less of the annual grant budget and may represent a comparatively accessible entry point for organizations working with tobacco-farming communities.

The following comparison uses the database's NTEE-matched peers (code S05, Community Development) as structural comparators by asset size. Note that none share Global Action's tobacco cessation mission — true mission peers would include Bloomberg Philanthropies (tobacco control), Robert Wood Johnson Foundation (health policy research), and Truth Initiative (cessation advocacy), but those are not included in this dataset.

Global Action holds the largest asset base among this NTEE-matched peer set at $152M (FY2023) and is the only pure scientific disease-area grantmaker in the group. Its annual giving figure of $31.7M in FY2023 — representing a 14% payout rate on assets — is consistent with endowed foundation norms and exceeds what most organizations of similar asset size distribute annually. The Society of Family Planning is the closest structural analog within this peer set: a research-focused health funder with an independent scientific review process, conflict-of-interest policies, and a defined clinical mission. Applicants already familiar with reproductive health research funders will find Global Action's application mechanics and standards recognizable.

The most consequential recent event in Global Action's institutional history was not a single grant but a financial restructuring: in FY2023, the organization received $140M in contributions — nearly four times its FY2022 contributions of $17.5M — lifting total assets from $40.1M to $152.1M. This endowment-scale influx, combined with the formal end of Philip Morris International funding in September 2023 and the organizational rebrand from Foundation for a Smoke-Free World, represents the defining transition in the organization's operating model.

In the months since, activity has accelerated. January 23, 2026 brought the first formal grant announcement under the organization's renewed identity, with the Urban Institute's Health Policy Center receiving funding for smoking cessation and public health research. A concurrent award to Northwell Health targeted evidence-based tobacco harm reduction care. February 2026 saw approvals for Strategic Health Research Limited (UK, Pakistan focus), Alternative Research Initiative (Pakistan, reapproval), and Knowledge Action Change (UK, global scope) — three international awards consistent with the LMIC priority.

On the organizational side, December 2025 brought the hire of Dr. Matt Walker as Program Officer, expanding grants management capacity. That same month, the organization published a public statement supporting the FDA's authorization of six on! nicotine pouch products — a visible policy positioning consistent with its harm-reduction philosophy. The 2026-2027 Strategic Plan, released in late 2025, formalized four goals: advancing the evidence base, increasing public awareness, facilitating access to cessation services, and amplifying global impact. Monthly newsletters continued through Q1 2026, with March 2025's 'Tobacco Harm Reduction Helps People Quit' and February 2025's 'Smart Nicotine Policy is a Social Justice Issue' tracking the harm-reduction messaging evolution.

Global Action's application process has several idiosyncrasies that differentiate it from standard foundation grant programs. The most important: preproposal submission through the online grants portal is the mandatory first stage for all pathways — RFP, solicited, and unsolicited. There is no direct full-proposal entry. The preproposal uses simplified templates and is reviewed by program staff before a full application invitation is extended. Treat the preproposal as your primary pitch, not a screening formality.

Track selection determines which templates and review criteria apply. The Health and Science Research track covers epidemiology, behavioral health, clinical studies, product research, policy, and economics. The Cessation Education track covers dissemination, implementation, and training for cessation services and harm reduction. Each track has Small Scale and Large Scale RFP designations — select based on project scope and budget, as the wrong designation signals poor self-assessment to program staff.

Language alignment with the organization's specific framing is a meaningful differentiator. Use the vocabulary the organization uses: "continuum of risk," "harm reduction," "marginalized communities," "low- and middle-income countries," "combustible tobacco," and "evidence-based cessation." Avoid the term "tobacco control," which carries WHO Framework Convention on Tobacco Control connotations — this organization explicitly operates outside the WHO tobacco control architecture and the framing signals misalignment.

Conflict-of-interest disclosure for all key personnel is non-negotiable. Any historical tobacco industry funding or affiliation will disqualify the application. Conversely, demonstrating prior experience working in LMICs, with marginalized populations, or on harm-reduction-aligned research strengthens eligibility signals. IRB approval (or a concrete timeline to obtain it) must be addressed for any human subjects research — do not submit without this in place.

Proposal documentation cannot include proprietary information, as materials may be shared with independent reviewers, consultants, and legal counsel. Budget and work plan templates are provided for each track — use them exactly as supplied. For portal technical issues, contact support@actiontoendsmoking.org. As of April 2026, no active grant cycle is open; subscribe to the Global Action Community newsletter and monitor globalactiontoendsmoking.org/grants/requests-for-proposal/ to be alerted when the next RFP window opens.